Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis

NCT00267306 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Ulcerative Colitis

Interventions

DRUG: Visilizumab

Sponsor

Facet Biotech

Collaborators

[object Object]